Articles by : Rich Daly, Editor in Chief

AHA Urges Dropping Bill Language to Exclude Generic Injectables from 340B

August 24, 2023 Views

The American Hospital Association opposed parts of draft legislation from the House E&C Committee concerning the 340B program.

The nation’s largest hospital advocacy organization urged legislators to drop a provision from draft legislation that would exclude generic injectables [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Provider-PhRMA Coalition Adds Civil Rights Group

August 24, 2023 Views

ASAP 340B, a coalition of a drug industry trade group and a community health center organization, added a civil rights group to its membership.

An alliance led by a powerful drug industry trade group and community health center organization that is pushing for 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

From the Publisher & CEO: The Big Question on the Minds of Every 340B Stakeholder

August 24, 2023 Views

340B stakeholders are anticipating two major contract pharmacy judicial rulings, including one from the Court of Appeals for the District of Columbia.

Amid nationwide uncertainty over both the legality of the scope of the 340B contract pharmacy program and the legality of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Maker Owes 340B Providers Repayment, HRSA Pending Audit Finds

August 22, 2023 Views

A HRSA fiscal year 2023 audit tentatively found that drug maker Nephron Pharmaceuticals owes 340B repayments to providers.

The first posted fiscal year 2023 audit of a drug maker tentatively found the company owes repayments to providers. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Drugs Among Those at Tornado-Hit Facility Requiring Direct Purchase

August 22, 2023 Views

Pfizer has limited multiple 340B-eligible drugs to direct purchase after a tornado damaged one of the drug maker's manufacturing facilities.

Federal officials confirmed that 340B-eligible drugs are among the 12 medications pharmaceutical manufacturer Pfizer has limited to direct purchase after [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Three Terminations, 10 Paybacks to Manufacturers in HRSA’s 2023 Pending Provider Audits

August 17, 2023 Views

HRSA audits found terminations were required for a 340B provider site and a contract pharmacy and that another provider owed repayments to drugmakers.

Three provider organizations may have contract pharmacies terminated from the 340B program and 10 providers would owe repayments to drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Lobbying Activity Experiences Historic Surge

August 15, 2023 Views

Lobbyists say Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023 in the absence of a major court decision.

The hiring of lobbyists in the congressional legislative fight over 340B was dominated by pharmaceutical firms and provider-manufacturer alliances in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHA Warns of “Legal Consequences” from Proposed Cuts to Fund 340B Lump Sum Payments

August 10, 2023 Views

The American Hospital Association opposed parts of draft legislation from the House E&C Committee concerning the 340B program.

The lead plaintiff in the legal battle that resulted in Medicare proposing an unusual lump sum payback for hospitals’ lost [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Medicare DSH Changes Will Cut 340B Access, Draw Legal Challenge, Say Attorneys

August 8, 2023 Views

CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.

Changes in the ways Medicare calculates hospitals’ shares of low-income patients that were finalized in a recent payment rule will [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospitals Charge Average 500% of Top 20 Drug Costs, Says PhRMA-Funded Analysis

August 8, 2023 Views

A Moran Company study, funded by PhRMA, found 340B hospitals charge an average of 500% above acquisition costs for 20 high-cost drugs.

Hospitals charge, on average, 500% of their acquisition cost for 20 individual medicines that account for the largest share of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live